Sanofi is to take on Boehringer Ingelheim's consumer health division in exchange for its animal health business Merial – the latest in a trend for multi-billion swaps in big pharma. The deal ...

Ingelheim, Germany Saturday, January 18, 2025, 11:00 Hrs [IST] ...

Critical pain points need to be overcome for the animal healthcare industry to achieve its full potential.

Boehringer Ingelheim today announced top-line results from the Phase III CONNEX clinical program in cognitive impairment in adults with ...

Guardant Health (GH) announced a collaboration with Boehringer Ingelheim to pursue the regulatory approval and commercialization of the Guardant360 CDx liquid biopsy as a companion diagnostic for ...

With 53,000 employees, it operates in over 130 markets, focusing on Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing. Established in 2003, Boehringer Ingelheim India ...

The MoU includes the implementation of formal stroke protocols for RED.Health ambulances and the ... one of tens of thousands against GSK, Boehringer Ingelheim and other pharmaceutical companies ...

The Western Canadian Association of Bovine Practitioners (WCABP) and Boehringer Ingelheim Animal Health Canada Inc. have ...

Boehringer Ingelheim today announced top-line results from the Phase III CONNEX clinical program in cognitive impairment in adults with schizophrenia, showing primary and key secondary endpoints were ...